Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial.
Karen H CostenbaderMitchell H GailI-Min LeeJill HahnJoseph WalterVadim BubesGregory KotlerNicole YangSonia FriedmanErik K AlexanderJoAnn E MansonPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Two years after trial termination, the protective effects of 2000 IU/day of vitamin D dissipated, but 1,000 mg/day of n-3 fatty acids had a sustained effect in reducing AD incidence.